食品与发酵工业 >

2024 , Vol. 50 >Issue 12: 1 - 8

DOI: https://doi.org/10.13995/j.cnki.11-1802/ts.037565

研究报告

人工蛋白XXA促进人源肿瘤抑素Tumstatin可溶性表达

  • 敖龙 ,
  • 朱玲玉 ,
  • 庞欣 ,
  • 辛瑜 ,
  • 郭忠鹏 ,
  • 朱瑞 ,
  • 李默影 ,
  • 顾正华 ,
  • 郭自涛 ,
  • 张梁
展开
  • 1(江南大学,粮食发酵与食品生物制造国家工程研究中心,江苏 无锡,214122)
    2(江苏大学 食品与生物工程学院,江苏 镇江,212013)
第一作者：硕士研究生(张梁教授和郭自涛讲师为共同通信作者,E-mail:zhangl@jiangnan.edu.cn;guozt@ujs.edu.cn)

收稿日期: 2023-10-07

  修回日期: 2023-10-20

  网络出版日期: 2024-07-11

基金资助

国家重点研发计划(2021YFC2100300)

收起

Artificial protein XXA promotes soluble expression of human-derived Tumstatin

  • AO Long ,
  • ZHU Lingyu ,
  • PANG Xin ,
  • XIN Yu ,
  • GUO Zhongpeng ,
  • ZHU Rui ,
  • LI Moying ,
  • GU Zhenghua ,
  • GUO Zitao ,
  • ZHANG Liang
Expand
  • 1(National Engineering Research center of Cereal Fermentation and Food Biomanufacturing Technology, Jiangnan University,Wuxi 214122, China)
    2(School of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, China)

Received date: 2023-10-07

  Revised date: 2023-10-20

  Online published: 2024-07-11

Fold

摘要

为实现人源肿瘤抑素Tumstatin在大肠杆菌中的可溶性表达,构建了5种不同促溶性融合标签与tumstatin基因融合表达的重组大肠杆菌BL21(DE3),利用异丙基-β-D-硫代半乳糖苷(isopropyl-β-D-thiogalactopyranoside,IPTG)诱导重组菌进行摇瓶发酵,利用SDS-PAGE和Western-Blot分析并筛选出能可溶性表达Tumstatin蛋白的重组菌。构建的重组菌中BL21/pGEX-6p-1-Tum(含谷胱甘肽巯基转移酶标签—GST标签)、BL21/pET28a-MBP-Tum(含麦芽糖结合蛋白标签—MBP标签)、BL21/pET28a-Tum(无标签)都是以包涵体的形式表达融合蛋白Tumstatin,只有重组菌BL21/pET28a-XXA-Tum(含抗冻蛋白的反向蛋白—XXA标签)能以可溶性的形式表达融合蛋白且目的蛋白占菌体总蛋白45%以上。利用亲和层析对目的蛋白进行纯化并进行Western-Blot分析,得到分子质量为50.9 kDa的目的条带,与理论分子质量一致。进一步对重组菌BL21/pET28a-XXA-Tum的诱导剂添加浓度、诱导剂添加时间、诱导温度、诱导时间诱导条件进行优化。最终选择Tumstatin融合蛋白诱导条件为:诱导剂浓度0.1 mmol/L、2 h添加诱导剂、诱导温度16 ℃、诱导时间36 h。人源肿瘤抑素在大肠杆菌中可溶性表达为大量制备可溶性人源肿瘤抑素奠定了基础,可为功能性多肽在大肠杆菌中的可溶性表达提供借鉴。

关键词： 人源肿瘤抑素; 大肠杆菌; 可溶性表达; 融合标签; 抗冻蛋白的反向蛋白

本文引用格式

敖龙 , 朱玲玉 , 庞欣 , 辛瑜 , 郭忠鹏 , 朱瑞 , 李默影 , 顾正华 , 郭自涛 , 张梁 . 人工蛋白XXA促进人源肿瘤抑素Tumstatin可溶性表达[J]. 食品与发酵工业, 2024 , 50(12) : 1 -8 . DOI: 10.13995/j.cnki.11-1802/ts.037565

Abstract

To realize the soluble expression of human-derived Tumstatin in Escherichia coli.Five recombinant E.coli (BL21(DE3)) expressed by fusion of different solubility-promoting fusion tags and tumstatin genes were constructed, and isopropyl-beta-D-thiogalactopyranoside (IPTG) was used to induce the recombinant bacteria to express the target protein.SDS-PAGE and Western-Blot were employed to analyze and screen for the recombinant bacteria that could solubility express Tumstatin.The results indicated that BL21/pGEX-6p-1-Tum (containing glutathione mercaptotransferase tag -GST tag), BL21/pET28a-MBP-Tum (containing maltose-binding protein tag-MBP tag), BL21/pET28a-Tum (no tag) all expressed the fusion protein Tumstatin in the form of inclusion bodies.Only the recombinant bacteria BL21/pET28a-XXA-Tum (containing the reverse protein of antifreeze protein-XXA tag) expressed fusion proteins in a soluble form, and the target protein accounts for more than 45% of the total protein of the bacteria.The target protein was purified by affinity chromatography and analyzed by Western-Blot.The band of interest with a molecular weight of 50.9 kDa was obtained, which was consistent with the theoretical molecular weight.Furthermore, the inducer concentration, addition time, induction temperature, and induction time of recombinant bacteria BL21/pET28a-XXA-Tum were optimized.Finally, the induction conditions of tumstatin fusion protein were selected as follows:Inducer concentration 0.1 mmol/L, inducer added at 2 h, induction temperature 16 ℃, induction time 36 h.The soluble expression of human Tumstatin in E.coli laid the foundation for the preparation of soluble human-derived Tumstatin in a large scale, which could provide a reference for the soluble expression of functional polypeptides in E.coli.

Key words： human-derived Tumstatin; Escherichia coli; soluble expression; fusion tags; reverse protein of antifreeze protein

参考文献

[1] FOLKMAN J.Tumor angiogenesis:Therapeutic implications[J].The New England Journal of Medicine, 1971, 285(21):1182-1186.
[2] MAESHIMA Y, COLORADO P C, TORRE A, et al.Distinct antitumor properties of a type IV collagen domain derived from basement membrane[J].The Journal of Biological Chemistry, 2000, 275(28):21340-21348.
[3] LEBLEU V S, DAI J L, TSUTAKAWA S, et al.Identification of unique α4 chain structure and conserved antiangiogenic activity of α3 NC1 type IV collagen in zebrafish[J].Developmental Dynamicsn, 2023, 252(7):1046-1060.
[4] MAESHIMA Y, COLORADO P C, KALLURI R.Two RGD-independent alpha vbeta3 integrin binding sites on tumstatin regulate distinct anti-tumor properties[J].The Journal of Biological Chemistry, 2000, 275(31):23745-23750.
[5] HAMANO Y, YZEISBERG M, SUGIMOTO H, et al.Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alpha vbeta3 integrin[J].Cancer Cell, 2003, 3(6):589-601.
[6] MAESHIMA Y, SUDHAKAR A, LIVELY J C, et al.Tumstatin, an endothelial cell-specific inhibitor of protein synthesis[J].Science, 2002, 295(5552):140-143.
[7] BOOSANI C S, MANNAM A P, COSGROVE D, et al.Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis[J].Blood, 2007, 110(4):1168-1177.
[8] 王淑静, 张艺, 刘佳, 等.肿瘤抑素抗肿瘤活性肽的研究进展[J].中国肿瘤, 2012, 21(1):56-59.
WANG S J, ZHANG Y, L J, et al.Research progress in anti-tumor peptide of tumstatin[J].China Cancer, 2012, 21(1):56-59
[9] DERRY C J, PICKERING M, BAKER C, et al.Identification of the Goodpasture antigen, alpha 3(IV) NC1, and four other NC1 domains of type IV collagen, by amino-terminal sequence analysis of human glomerular basement membrane separated by two-dimensional electrophoresis[J].Experimental Nephrology, 1994, 2(4):249-256.
[10] 顾取良, 张添元, 罗进贤, 等.人Tumstatin在毕赤酵母中的表达和活性分析[J].生物工程学报, 2006, (3):451-456.
GU Q L, ZHANG T Y, LUO J X, et al.Expression of human tumstatin in Pichia pastoris and its bioactivity[J].Chinese Journal of Biotechnology, 2006,22(3):451-456.
[11] ESIPOV R, BEYRAKHOVA K, LIKHVANTSEVA V, et al.Antiangiogenic and antivascular effects of a recombinant tumstatin-derived peptide in a corneal neovascularization model[J].Biochimie, 2012, 94(6):1368-1375.
[12] 姚丽娟. 重组融合蛋白Tumstatin-EGFP分泌型真核表达以及生物活性的研究[D];合肥:安徽医科大学, 2009.
YAO L J.Secreted eukaryotic expression and biological activity of recombinent fusion protein Tumstatin-EGFP[D];Hefei:Anhui Medical University, 2009.
[13] LUO Y Q, WANG L H, YI Q, et al.Expression of soluble, biologically active recombinant human tumstatin in Escherichia coli[J].Clinical and Experimental Medicine, 2008, 8(1):37-42.
[14] 颜廷东. 人肿瘤抑素的克隆、表达及其生物活性实验研究[D].北京:中国协和医科大学, 2007.
YAN T D.The study of cloning,expression and bioassay of human tumstatin[D].Beijing:Peking Union Medical College, 2007.
[15] GU Q L, ZHANG T Y, LUO J X, et al.Expression, purification, and bioactivity of human tumstatin from Escherichia coli[J].Protein Expression and Purification, 2006, 47(2):461-466.
[16] ESPOSITO D, CHATTERJEE D K.Enhancement of soluble protein expression through the use of fusion tags[J].Current Opinion in Biotechnology, 2006, 17(4):353-358.
[17] YARI K, AFZALI S, MOZAFARI H, et al.Molecular cloning, expression and purification of recombinant soluble mouse endostatin as an anti-angiogenic protein in Escherichia coli[J].Molecular Biology Reports, 2013, 40(2):1027-1033.
[18] LIOU Y-C, TOCILJ A, DAVIES P L, et al.Mimicry of ice structure by surface hydroxyls and water of a β-helix antifreeze protein[J].Nature, 2000, 406(6793):322-324.
[19] SUN T J, LIN F-H, CAMPBELL R L, et al.An antifreeze protein folds with an interior network of more than 400 semi-clathrate waters[J].Science, 2014, 343(6172):795-798.
[20] XIE X, WU P, HUANG X C, et al.Retro-protein XXA is a remarkable solubilizing fusion tag for inclusion bodies[J].Microbial Cell Factories, 2022, 21(1):51.
[21] 李正杰, 顾正华, 石贵阳, 等.Nanog蛋白在大肠杆菌中的可溶性表达及发酵优化[J].食品与发酵工业, 2020, 46(17):15-21.
LI Z J, GU Z H, SHI G Y, et al.Soluble expression of human Nanog protein in Escherichia coli and its fermentation optimization[J].Food and Fermentation Industries, 2020, 46(17):15-21.
[22] DUAN X G, CHEN J, WU J.Optimization of pullulanase production in Escherichia coli by regulation of process conditions and supplement with natural osmolytes[J].Bioresource Technology, 2013, 146:379-385.
[23] ZOU C, DUAN X, WU J.Enhanced extracellular production of recombinant Bacillus deramificans pullulanase in Escherichia coli through induction mode optimization and a glycine feeding strategy[J].Bioresource Technology, 2014, 172:174-179.
[24] YUAN S L, DUAN H Q, LIU C J, et al.The role of thioredoxin and disulfide isomerase in the expression of the snake venom thrombin-like enzyme calobin in Escherichia coli BL21 (DE3)[J].Protein Expression and Purification, 2004, 38(1):51-60.
[25] DUAN X G, HU S B, QI X H, et al.Optimal extracellular production of recombinant Bacillus circulans β-galactosidase in Escherichia coli BL21(DE3)[J].Process Biochemistry, 2017, 53:17-24.
[26] SU L Q, JIANG Q, YU L G, et al.Enhanced extracellular production of recombinant proteins in Escherichia coli by co-expression with Bacillus cereus phospholipase C[J].Microbial Cell Factories, 2017, 16(1):24.
[27] DYSON M R, SHADBOLT S P, VINCENT K J, et al.Production of soluble mammalian proteins in Escherichia coli:Identification of protein features that correlate with successful expression[J].BMC Biotechnology, 2004, 4(1):32.
[28] HAMMARSTRÖM M, HELLGREN N, VAN DEN BERG S, et al.Rapid screening for improved solubility of small human proteins produced as fusion proteins in Escherichia coli[J].Protein Science, 2002, 11(2):313-321.
Options
文章导航

/

〈 〉

技术支持：北京玛格泰克科技发展有限公司